Andrea Califano began his career as a physicist. But that’s not why he’s now calling cancer a quantum disease. “We’re really just following the data,” says Califano, the Clyde ’56 and Helen Wu Professor of Chemical Biology at Columbia University Vagelos College of Physicians and Surgeons and head of Biohub, New York.
GENEVA, Aug. 26, 2026 /PRNewswire/ — Spineart, a global fast-growing company in spine surgery innovation, and eCential Robotics today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the PERLA® TL application (PERLA® by Spineart app) for use with the eCential® Op.n® Navigation and Robotic-Assisted Platform.
Gastroesophageal adenocarcinoma presents the biggest market opportunity for Jazz Pharmaceuticals’ Ziihera, according to Truist Securities, which forecasts peak sales of the drug to reach $2.5 billion.
The Libre Duo 10 Day sensor delivers up to ten days of continuous monitoring with ongoing readings, not single-point measurements.
The University of Tokyo and Institute of Science Tokyo’s AI detected diabetes with accuracy >80% from 30-second and five-seconds recordings.
In a new study, Mass General Brigham researchers explore the causes of immune aging, a barrier to successful cancer immunotherapy, and identify a gene that may serve as an age-related prognostic marker and potential target for future cancer therapies.
Poor sleep quality has been linked to cognitive decline, neurodegeneration and Alzheimer’s disease in older adults. A new international study led by Concordia researchers and published in the journal Neurology shows that specific sleep brain waves provide protection against the harmful effects of a brain chemical usually associated with wakefulness and sleep transition.
Bladder cancer claims 220,000 lives globally each year, with symptoms sometimes mistaken for other conditions such as kidney stones. Now researchers have developed an artificial intelligence system that can identify bladder cancer patients up to five years before their official diagnosis, potentially revolutionizing screening for the disease.
Researchers at NYU Abu Dhabi have developed BRIDGE (Biodegradable aRchitected Internal DrainaGE), a biodegradable, 3D-printed gastric stent that could improve treatment for gastric leaks, a serious complication following weight-loss surgery.
Kidney disease is silent in its early stages, progressing without symptoms until the disease is advanced. Researchers in the McKelvey School of Engineering at Washington University in St. Louis, in collaboration with researchers at WashU Medicine and Texas A&M University, have been developing a minimally invasive method to improve diagnosis at earlier stages.